Skip to main content
. Author manuscript; available in PMC: 2022 Sep 15.
Published in final edited form as: Am J Nephrol. 2021 Sep 15;52(9):745–752. doi: 10.1159/000518652

Table 3.

Association of baseline factors with baseline coronary arterial calcification and progression of calcification by Agatston and calcium volume scores.

Variable Baseline CAC CAC Progression CAC progression by
Calcium Volume Score
Coefficient
±SE
P value Coefficient
±SE
P value Coefficient
±SE
P value
Age 0.03±0.02 0.11 4.98±6.18 0.42 0.1±0.07 0.13
Female sex −0.06±0.48 0.9 −169.36±123.38 0.18 −2.06±1.34 0.13
African Americans −0.98±0.49 0.05 128.17±137.22 0.36 2.15±1.5 0.16
Diabetes Status 1.47±0.48 0.003 61.35±132.20 0.65 1.62±1.44 0.27
Ever Smoker 2.03±0.5 <0.001 5.03±149.06 0.97 −1.48±1.62 0.37
Baseline CAC (log) - - 41.55±30.09 0.17 0.50±0.33 0.14
Serum phosphate −0.41±0.19 0.04 −92.14±58.29 0.12 −0.58±0.63 0.36
IL-6 (log) 0.74±0.31 0.02 177.38±88.97 0.05 2.01±0.97 0.04
FGF-23 (log) 0.40±0.25 0.11 174.52±71.96 0.02 1.86±0.78 0.02

Models adjusted for age, gender, race, smoking status, diabetes status, serum phosphate, FGF23 and IL-6.